WHO ICTRP trial
Tumour-specific fluorescence-guided surgery for gastroenteropancreatic…
NL-OMON26268 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON26268 |
|---|---|
| Public title | Tumour-specific fluorescence-guided surgery for gastroenteropancreatic neuroendocrine neoplasms using PHT001: a phase 1, open-label, single-arm, dose-escalation study |
| Scientific title | Tumour-specific fluorescence-guided surgery for gastroenteropancreatic neuroendocrine neoplasms using PHT001: a phase 1, open-label, single-arm, dose-escalation study |
| Primary sponsor | Amsterdam UMC |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Conditions | Gastroenteropancreatic neuroendocrine neoplasms |
| Interventions | Single bolus injection of PHT001 |
| Registration date | Feb 19, 2021 |
| Target size | 15 |
| Secondary IDs | NL9298;METC AMC : Pending |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: